Skip to main content

Hormonal Changes in Cardiac Syndrome X – Role of Testosterone

  • Chapter
  • First Online:
Chest Pain with Normal Coronary Arteries

Abstract

Cardiac Syndrome X occurs predominately in peri- or post-menopausal women. The onset of the chest pain associated with Cardiac Syndrome X coincides with the menopause or hysterectomy and the related decrease in circulating ovarian hormones. As well as estrogens and progestogens, testosterone is synthesized in the ovaries and adrenal glands of women, and has important physiological actions in women, either directly via androgen receptors or as precursors of estrogen production. Testosterone replacement can be given to menopausal women, with or without estrogen, to increase libido, relieve menopausal symptoms, increase bone density and improve quality of life. As well as chest pain, common symptoms of Cardiac Syndrome X include tiredness and lethargy, and it is feasible that reduced androgen concentrations may be involved in the pathophysiology of the syndrome. Relatively few studies have investigated the effects of testosterone replacement in women, and even fewer in women with Cardiac Syndrome X. Further studies are needed to better understand the role of testosterone in the pathophysiology and treatment of Cardiac Syndrome X.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kaski JC, Rosano GMC, Collins P, Nihoyannopoulos P, Maseri A, Poole-Wilson PA. Cardiac syndrome X: clinical characteristics and left ventricular function. Long term follow-up study. J Am Coll Cardiol. 1995;25:807–14.

    Article  PubMed  CAS  Google Scholar 

  2. Rosano GMC, Collins P, Kaski JC, Lindsay DC, Sarrel PM, Poole-Wilson PA. Syndrome X in women is associated with estrogen deficiency. Eur Heart J. 1995;16:610–4.

    PubMed  CAS  Google Scholar 

  3. Sarrel PM, Lindsay DC, Rosano GMC, Poole-Wilson PA. Angina and normal coronary arteries in women. Gynecologic findings. Am J Obstet Gynecol. 1992;167:467–71.

    PubMed  CAS  Google Scholar 

  4. Rosano GMC, Peters NS, Lefroy DC, Lindsay DC, Sarrel PM, Collins P, et al. 17-Beta-estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol. 1996;28: 1500–5.

    Article  PubMed  CAS  Google Scholar 

  5. Burger HG. Androgen production in women. Fertil Steril. 2002;77 Suppl 4:S3–5.

    Article  PubMed  Google Scholar 

  6. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005;90:3847–53.

    Article  PubMed  CAS  Google Scholar 

  7. Arlt W. Androgen therapy in women. Eur J Endocrinol. 2006;154:1–11.

    Article  PubMed  CAS  Google Scholar 

  8. Savvas M, Studd JW, Norman S, Leather AT, Garnett TJ, Fogelman I. Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens. Br J Obstet Gynaecol. 1992;99(9):757–60.

    Article  PubMed  CAS  Google Scholar 

  9. Montgomery JC, Appleby L, Brincat M, Versi E, Tapp A, Fenwick PB, et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet. 1987;1(8528):297–9.

    Article  PubMed  CAS  Google Scholar 

  10. Burger HG, Hailes J, Menelaus M, Nelson J, Hudson B, Balazs N. The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical, lipid and hormonal results. Maturitas. 1984;6(4):351–8.

    Article  PubMed  CAS  Google Scholar 

  11. Frock J, Money J. Sexuality and menopause. Psychother Psychosom. 1992;57:29–33.

    Article  PubMed  CAS  Google Scholar 

  12. Hallstrom T. Sexuality in the climacteric. Clin Obstet Gynaecol. 1977;4:227–39.

    PubMed  CAS  Google Scholar 

  13. Sands R, Studd J. Exogenous androgens in postmenopausal women. Am J Med. 1995;98:76S–9.

    Article  PubMed  CAS  Google Scholar 

  14. Steinberg KK, Freni-Titulaer LW, DePuey EG, Miller DT, Sgoutas DS, Coralli CH, et al. Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab. 1989;69:533–9.

    Article  PubMed  CAS  Google Scholar 

  15. Worboys S, Kotsopoulos D, Teede H, McGrath B, Davis SR. Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilation in postmenopausal women already receiving estrogen. J Clin Endocrinol Metab. 2001;86:158–61.

    Article  PubMed  CAS  Google Scholar 

  16. Davis SR, Moreau M, Kroll R, Bouchard C, Panay N, Gass M, et al. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med. 2008;359(19):2005–17.

    Article  PubMed  CAS  Google Scholar 

  17. Bachmann G, Bancroft J, Braunstein G, Burger H, Davis S, Dennerstein L, et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril. 2002;77:660–5.

    Article  PubMed  Google Scholar 

  18. Wu SZ, Weng XZ. Therapeutic effects of an androgenic preparation on myocardial ischemia and cardiac function in 62 elderly male coronary heart disease patients. Chin Med J (Engl). 1993;106: 415–8.

    CAS  Google Scholar 

  19. Alexandersen P, Haarbo J, Christiansen C. The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis. 1996;125:1–13.

    Article  PubMed  CAS  Google Scholar 

  20. Cornoldi A, Caminiti G, Marazzi G, Vitale C, Patrizi R, Volterrani M, et al. Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease. Int J Cardiol. 2009;142(1):50–5.

    Article  PubMed  Google Scholar 

  21. Webb CM, Elkington AG, Kraidly MM, Keenan N, Pennell DJ, Collins P. Effects of oral testosterone treatment on myocardial perfusion and vascular function in men with low plasma testosterone and coronary heart disease. Am J Cardiol. 2008;101(5):618–24.

    Article  PubMed  CAS  Google Scholar 

  22. Malkin CJ, Pugh PJ, Morris PD, Kerry KE, Jones RD, Jones TH, et al. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart. 2004;90:871–6.

    Article  PubMed  CAS  Google Scholar 

  23. English KM, Steeds RP, Jones TH, Diver MJ, Channer KS. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, ­placebo- controlled study. Circulation. 2000;102(16):1906–11.

    Article  PubMed  CAS  Google Scholar 

  24. Merz CN, Olson MB, McClure C, Yang YC, Symons J, Sopko G, et al. A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE). Am Heart J. 2010;159:987.

    Article  PubMed  Google Scholar 

  25. Adamson DL, Webb CM, Collins P. Esterified estrogens combined with methyltestosterone improve emotional well-being in postmenopausal women with chest pain and normal coronary angiograms. Menopause. 2001;8(4):233–8.

    Article  PubMed  CAS  Google Scholar 

  26. Walker TC. The use of testosterone propionate and estrogenic substance in the treatment of essential hypertension, angina pectoris and peripheral vascular disease. J Clin Endocrinol Metab. 1942;2:560–8.

    Article  CAS  Google Scholar 

  27. Lesser MA. Testosterone propionate therapy in one hundred cases of angina pectoris. J Clin Endocrinol Metab. 1946;6:549–57.

    Article  PubMed  CAS  Google Scholar 

  28. Hamm L. Testosterone propionate in the treatment of angina pectoris. J Clin Endocrinol Metab. 1942;2:325–8.

    Article  Google Scholar 

  29. Phillips GB, Pinkernell BH, Jing TY. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb. 1994;14:701–6.

    Article  PubMed  CAS  Google Scholar 

  30. Nordoy A, Aakvaag A, Thelle D. Sex hormones and high density lipoproteins in healthy males. Atherosclerosis. 1979;34:431–6.

    Article  PubMed  CAS  Google Scholar 

  31. Heller RF, Miller NE, Lewis B, Vermeulen A, Fairney A, James VHT, et al. Associations between sex hormones, thyroid hormones and lipoproteins. Clin Sci. 1981;61:649–51.

    PubMed  CAS  Google Scholar 

  32. Gutai J, LaPorte R, Kuller L, Dai W, Falvo-Gerard L, Caggiula A. Plasma testosterone, high density lipoprotein cholesterol and other lipoprotein fractions. Am J Cardiol. 1981;48:897–902.

    Article  PubMed  CAS  Google Scholar 

  33. English KM, Mandour O, Steeds RP, Diver MJ, Jones TH, Channer KS. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J. 2000;21:890–4.

    Article  PubMed  CAS  Google Scholar 

  34. Yue P, Chatterjee K, Beale C, Poole-Wilson PA, Collins P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation. 1995;91:1154–60.

    Article  PubMed  CAS  Google Scholar 

  35. Chou TM, Sudhir K, Hutchison SJ, Ko E, Amidon TM, Collins P, et al. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation. 1996;94:2614–9.

    Article  PubMed  CAS  Google Scholar 

  36. Honore EK, Williams JK, Adams MR, Ackerman DM, Wagner JD. Methyltestosterone does not diminish the beneficial effects of estrogen replacement therapy on coronary artery reactivity in cynomolgus monkeys. Menopause. 1996;3(1):20–6.

    Article  Google Scholar 

  37. Ong PJL, Patrizi G, Chong WCF, Webb CM, Hayward CS, Collins P. Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease. Am J Cardiol. 2000;85:14–7.

    Article  Google Scholar 

  38. Webb CM, McNeill JG, Hayward CS, de Ziegler D, Collins P. Effects of testosterone on coronary vasomotor regulation in men with coronary artery disease. Circulation. 1999;100:1690–6.

    Article  PubMed  CAS  Google Scholar 

  39. Webb CM, Adamson DL, de Ziegler D, Collins P. Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. Am J Cardiol. 1999;83:437–9.

    Article  PubMed  CAS  Google Scholar 

  40. Rosano GMC, Leonardo F, Pagnotta P, Pelliccia F, Panina G, Cerquetani E, et al. Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation. 1999;99:1666–70.

    Article  PubMed  CAS  Google Scholar 

  41. McCredie RJ, McCrohon JA, Turner L, Griffiths KA, Handelsman DJ, Celermajer DS. Vascular reactivity is impaired in genetic females taking high-dose androgens. J Am Coll Cardiol. 1998;32:1331–5.

    Article  PubMed  CAS  Google Scholar 

  42. Sherwin BB, Gelfand MM. Sex steroids and affect in the surgical menopause: a double-blind, cross-over study. Psychoneuroendocrinology. 1985;10:325–35.

    Article  PubMed  CAS  Google Scholar 

  43. Sherwin BB, Gelfand MM. Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol. 1985;151:153–60.

    PubMed  CAS  Google Scholar 

  44. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med. 2000;343:682–8.

    Article  PubMed  CAS  Google Scholar 

  45. Miller KK, Biller BM, Beauregard C, Lipman JG, Jones J, Schoenfeld D, et al. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2006;91:1683–90.

    Article  PubMed  CAS  Google Scholar 

  46. Shufelt CL, Braunstein GD. Safety of testosterone use in women. Maturitas. 2009;63:63–6.

    Article  PubMed  CAS  Google Scholar 

  47. Shufelt CL, Braunstein GD. Testosterone and the breast. Menopause Int. 2008;14(3):117–22.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carolyn M. Webb PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Webb, C.M., Collins, P. (2013). Hormonal Changes in Cardiac Syndrome X – Role of Testosterone. In: Kaski, J., Eslick, G., Bairey Merz, C. (eds) Chest Pain with Normal Coronary Arteries. Springer, London. https://doi.org/10.1007/978-1-4471-4838-8_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4838-8_28

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4837-1

  • Online ISBN: 978-1-4471-4838-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics